Despite a 27% reduction in all-cause mortality from targeting a systolic blood pressure of < 120 mm Hg, as compared with < 140 mm Hg, existing quality measures from the NCQA for controlling HBP (for hypertensive adults 18-59 years of age whose blood pressure was < 140/90 mm Hg) have not changed substantially over the past several years for a variety of insured populations, including commercial, Medicaid, Medicare Fee for Service and Medicare Advantage. Re-examining both the targets and processes of managing HBP are thus warranted to help support the use of the latest evidence in optimizing the quality of care and outcomes for patients with HBP. The recently published 2019 ACC/AHA Clinical Performance and Quality Measures for Adults with High Blood Pressure are designed to promote improvements in diagnosis and control of high blood pressure, including a new emphasis on “structural” quality measures that focus on a comprehensive system of care as outlined in the 2017 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. The purpose of this presentation will be to provide a detailed overview of this new measure set as a “Blueprint for Change” necessary to overcome current health system inertia and ensure the achievement of better quality of care for people with High Blood Pressure.
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure
